Literature DB >> 15892423

The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review.

Jordana K Schmier1, Michael T Halpern, Mitchell K Higashi, Alan Bakst.   

Abstract

BACKGROUND: The impact of acute exacerbations of chronic bronchitis (AECB), a common consequence of chronic obstructive pulmonary disease (COPD), is extensive, with symptoms ranging from mild to life threatening. Health-related quality of life (HRQL) is impaired in patients with COPD, but little is known about the direct effect of exacerbations on HRQL.
METHODS: MEDLINE and EMBASE literature searches were conducted; reference lists of identified articles were reviewed.
RESULTS: Eighteen studies reporting the impact on HRQL of acute exacerbations were identified. Study design and patient population varied. Six studies evaluated HRQL once; only four studies used both generic and disease-specific HRQL measures. Cross-sectional studies reported HRQL decrements during exacerbations and suggested that HRQL is a good predictor of health care resource utilization. Pharmacological treatment led to within-group improvements following AECBs. Non-pharmacological intervention studies were small and inconclusive. Longitudinal studies, assessing pharmacological and non-pharmacological interventions, found that HRQL improved from exacerbation to recovery, with responsiveness depending on sensitivity of the measure. Frequency of exacerbations was a significant predictor of HRQL.
CONCLUSIONS: Exacerbations lead to substantial reductions in HRQL, both in physical as well as other domains. Further research should assess the impact of specific treatment regimens and the timeline for the recovery process.

Entities:  

Mesh:

Year:  2005        PMID: 15892423     DOI: 10.1007/s11136-004-0625-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  52 in total

Review 1.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

3.  Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

Authors:  Maria T Britto; Uma R Kotagal; Richard W Hornung; Harry D Atherton; Joel Tsevat; Robert W Wilmott
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

4.  Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D).

Authors:  C Paterson; C E Langan; G A McKaig; P M Anderson; G D Maclaine; L B Rose; S J Walker; M J Campbell
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.

Authors:  J Lorenz; I M Thate-Waschke; O Mast; R Kubin; R Rychlik; T Pfeil; D Daniel; G S Tillotson
Journal:  J Int Med Res       Date:  2001 Mar-Apr       Impact factor: 1.671

6.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

7.  Health-related quality of life in long-term oxygen-treated chronic obstructive pulmonary disease patients.

Authors:  T H Hoang Thi; F Guillemin; A Cornette; J M Polu; S Briançon
Journal:  Lung       Date:  1997       Impact factor: 2.584

8.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Authors:  S Spencer; P W Jones
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

9.  Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.

Authors:  S Chodosh; A Schreurs; G Siami; H W Barkman; A Anzueto; M Shan; H Moesker; T Stack; S Kowalsky
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

10.  Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile.

Authors:  Helen Doll; Isabelle Duprat-Lomon; Erika Ammerman; Pierre-Philippe Sagnier
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

View more
  19 in total

1.  [Pelargonium sidoides in acute bronchitis - Health-related quality of life and patient-reported outcome in adults receiving EPs 7630 treatment].

Authors:  Heinrich Matthys; Victor G Lizogub; Petra Funk; Fathi A Malek
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 2.  Pulmonary rehabilitation in patients with an acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Sarah E Jones; Ruth E Barker; Claire M Nolan; Suhani Patel; Matthew Maddocks; William D C Man
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study.

Authors:  James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer
Journal:  Psychosom Med       Date:  2014-10       Impact factor: 4.312

Review 4.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

5.  Factors associated with short-term recovery of health status among emergency department patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Chu-Lin Tsai; Brian H Rowe; Carlos A Camargo
Journal:  Qual Life Res       Date:  2009-01-04       Impact factor: 4.147

6.  Changes in health status, psychological distress, and quality of life in COPD patients after hospitalization.

Authors:  Randi Andenaes; Torbjørn Moum; Mary H Kalfoss; Astrid K Wahl
Journal:  Qual Life Res       Date:  2006-03       Impact factor: 4.147

7.  Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations.

Authors:  Debra E Irwin; Charles A Atwood; Ron D Hays; Karen Spritzer; Honghu Liu; James F Donohue; Nancy Kline Leidy; Susan E Yount; Darren A DeWalt
Journal:  Qual Life Res       Date:  2014-10-12       Impact factor: 4.147

8.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

Authors:  Meilan K Han; Ella A Kazerooni; David A Lynch; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Gerard J Criner; Victor Kim; Russell P Bowler; Nicola A Hanania; Antonio R Anzueto; Barry J Make; John E Hokanson; James D Crapo; Edwin K Silverman; Fernando J Martinez; George R Washko
Journal:  Radiology       Date:  2011-07-25       Impact factor: 11.105

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice-The "AIOLOS" Study.

Authors:  Konstantinos Gourgoulianis; Alessandro Ruggieri; Alessandra Del Vecchio; Fabrizio Calisti; Alessandro Comandini; Giovanna Esposito; Giorgio Di Loreto; Nikolaos Tzanakis
Journal:  Can Respir J       Date:  2021-05-25       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.